# RadNet, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/RadNet, Inc.).

## Overview

RadNet, Inc. operates outpatient diagnostic imaging centers across the United States and also runs a digital health business focused on radiology software and AI tools. Its imaging network provides MRI, CT, PET, mammography, ultrasound, X-ray, fluoroscopy, and related services, while its Digital Health segment develops cloud-based workflow, image management, and clinical AI products for radiology providers.

## Products & services

• Outpatient diagnostic imaging services
• MRI, CT, PET and nuclear medicine scans
• Mammography, ultrasound and X-ray services
• Fluoroscopy and related imaging procedures
• RIS/PACS and radiology workflow software
• Clinical AI for breast, lung and prostate imaging

- **Imaging Centers** (97%) — Freestanding outpatient diagnostic imaging services delivered through owned and joint-venture centers.
- **Digital Health** (3%) — AI-enabled radiology software, workflow, and image management products sold to providers.

- Outpatient diagnostic imaging services
- MRI, CT, PET and nuclear medicine scans
- Mammography, ultrasound and X-ray services
- Fluoroscopy and related imaging procedures
- RIS/PACS and radiology workflow software
- Clinical AI for breast, lung and prostate imaging

## Customers

RadNet serves patients referred by physicians, along with the payors that reimburse imaging services, including commercial insurers, Medicare, Medicaid, and managed care organizations. Its Digital Health products are sold to outpatient radiology groups, hospital systems, and other healthcare organizations that need RIS/PACS, enterprise imaging, and AI-assisted interpretation tools.

- **Referred imaging patients** (primary) — Patients sent by physicians for MRI, CT, PET, mammography, ultrasound, and other scans.
- **Commercial and managed care payors** (primary) — Insurers and capitated payors that reimburse most imaging service revenue.
- **Government payors** (secondary) — Medicare and Medicaid programs that reimburse a meaningful share of imaging volume.
- **Radiology practices and imaging centers** (primary) — Customers for RIS/PACS, workflow, and AI tools that improve interpretation and operations.
- **Hospital and health system providers** (secondary) — Buy enterprise imaging, remote scanning, and AI solutions for larger care networks.

- Patients referred for outpatient imaging exams
- Commercial insurers and managed care payors
- Medicare and Medicaid reimbursement programs
- Radiology groups and outpatient imaging operators
- Hospital and health system customers for software and AI

## Geography

RadNet’s imaging business is concentrated in the United States, with centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, Texas, and Virginia. It also has international exposure through teleradiology and digital health activities in the United Kingdom and the Netherlands, which support remote interpretation and software development.

- **United States** (95%) — Imaging center network is primarily U.S.-based
- **United Kingdom** (3%) — Teleradiology and image exchange services
- **Europe (other)** (2%) — Digital health development and acquired software assets

- Imaging centers are concentrated in major U.S. metropolitan markets
- Core states include California, New York, Florida, Texas and others
- Joint ventures extend the center network into hospital systems
- UK teleradiology supports remote interpretation for NHS providers
- Netherlands-based digital health assets support AI product development

## Strategy

RadNet’s strategy is to densify its imaging footprint in selected regional markets while using scale to deepen relationships with payors, physicians, and health systems. It is also building a commercial digital health platform around DeepHealth OS, RIS/PACS, and clinical AI to expand beyond imaging centers into enterprise software and workflow solutions.

- **Grow and densify the imaging center network** (medium-term) — Higher local density supports referral relationships, operating leverage, and broader modality coverage.
- **Scale Digital Health commercialization** (medium-term) — Software and AI products can extend the business beyond physical centers and deepen customer relationships.
- **Increase multi-modality utilization** (short-term) — One-site access to multiple procedures improves convenience for patients and referral sources.
- **Expand international software reach** (medium-term) — International customers broaden the addressable market for AI and workflow tools.

- Expand imaging density in selected U.S. regional markets
- Use acquisitions and joint ventures to add centers and capabilities
- Leverage multi-modality sites to serve more procedures per location
- Scale Digital Health through enterprise imaging and AI products
- Broaden international commercialization of software and AI

## Risks

RadNet is exposed to reimbursement pressure, payor mix shifts, and utilization changes because most revenue comes from reimbursed diagnostic procedures. It also faces cybersecurity, privacy, and technology risks tied to handling sensitive patient data and operating connected imaging and software systems.

- **Reimbursement pressure from commercial, government, or managed care payors** [high] — Imaging revenue depends on negotiated rates and reimbursement policies across payor classes.
- **Cybersecurity and ransomware incidents** [high] — The business stores and transmits sensitive medical data across clinical and software systems.
- **Privacy and data protection compliance** [high] — Patient information is subject to HIPAA, GDPR, and state privacy laws.
- **Capital intensity and equipment/facility investment needs** [medium] — Centers require ongoing investment in imaging equipment, leases, and technology.
- **Integration risk from acquisitions and joint ventures** [medium] — Growth has relied on adding centers and software businesses that must be integrated operationally.

- Reimbursement changes can affect imaging economics
- Payor mix shifts influence realized service revenue
- Cyberattacks can disrupt operations and expose patient data
- HIPAA, GDPR and state privacy rules increase compliance burden
- Capital intensity creates execution risk for center and equipment growth

## Accounting

Revenue is recognized when diagnostic services are performed, generally over a very short service period, but reported revenue depends on estimates for contractual allowances, discounts, and implicit price concessions. Investors should also watch goodwill and intangible assets from acquisitions, lease accounting for a large center footprint, and the valuation of joint ventures and other fair-value estimates.

- **Revenue recognition and contractual allowances** — Affects net service revenue and comparability across payor classes
- **Lease accounting** — Affects balance sheet liabilities and operating expense presentation
- **Goodwill and intangible assets** — Could create non-cash charges if acquired businesses underperform
- **Joint venture accounting** — Affects revenue, equity earnings, and noncontrolling interests
- **Fair value of interest rate swaps and debt-related items** — Can create volatility in other income and expense

- Net patient revenue depends on contractual allowances and price concessions
- Service revenue is recognized when imaging services are delivered
- Lease accounting is important given the large center footprint
- Acquisition-related goodwill and intangibles may require impairment testing
- Joint ventures and fair-value estimates can affect reported earnings

---

*Last updated: 2026-04-29T04:52:44.070722+00:00*